| Leman SKL SA - Rativor 4 mg/ml, solution injectable |
| 69641 | | 01 | | Rativor 4 mg/ml | | solution injectable | | N05BA06 | | Lorazepam | | 20.09.2024 | | |
|
| Composition |
| lorazepamum 4 mg, propylenglycolum 840 mg, macrogolum 400, alcohol benzylicus 21 mg ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Lorazepam | 4 mg/ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Alcohol Benzylicus | 21 mg/ml | | Macrogol | 400 | | Propylenglycol | 840 mg/ml |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 x 1 ml | DDP | DDP | B | | Non | | 002 | 10 x 1 ml | DDP | DDP | B | | Non |
|
